Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease

被引:3
|
作者
Cheng, Wei -Chun [1 ,2 ,3 ]
Wong, Pei-Yi [4 ]
Wu, Chih-Da [5 ,6 ,7 ]
Cheng, Pin -Nan [2 ]
Lee, Pei -Chen [1 ]
Li, Chung-Yi [1 ,8 ,9 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan, Taiwan
[3] Minist Hlth & Welf, Tainan Hosp, Dept Gastroenterol & Hepatol, Tainan, Taiwan
[4] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Tainan, Taiwan
[5] Natl Cheng Kung Univ, Dept Geomat, Tainan, Taiwan
[6] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan
[7] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr, Taichung, Taiwan
[8] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[9] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
Metabolic dysfunction-associated steatotic liver disease (MASLD); Air pollutants; Particular matters; Risk factors; Epidemiologic study; Restricted cubic spline (RCS); AMERICAN-COLLEGE; MANAGEMENT; MORTALITY; HEALTH; GUIDELINES; DIAGNOSIS;
D O I
10.1265/ehpm.23-00271
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Metabolic Dysfunction -associated Steatotic Liver Disease (MASLD) has become a global epidemic, and air pollution has been identified as a potential risk factor. This study aims to investigate the non-linear relationship between ambient air pollution and MASLD prevalence. Method: In this cross-sectional study, participants undergoing health checkups were assessed for three-year average air pollution exposure. MASLD diagnosis required hepatic steatosis with at least 1 out of 5 cardiometabolic criteria. A stepwise approach combining data visualization and regression modeling was used to determine the most appropriate link function between each of the six air pollutants and MASLD. A covariate-adjusted six -pollutant model was constructed accordingly. Results: A total of 131,592 participants were included, with 40.6% met the criteria of MASLD. "Threshold link function," "interaction link function," and "restricted cubic spline (RCS) link functions" best -fitted associations between MASLD and PM2.5, PM10/CO, and O3 /SO2/NO2, respectively. In the six -pollutant model, significant positive associations were observed when pollutant concentrations were over: 34.64 mu g/m3 for PM2.5, 57.93 mu g/m3 for PM10, 56 mu g/m3 for O3, below 643.6 mu g/m3 for CO, and within 33 and 48 mu g/m3 for NO2. The six -pollutant model using these best -fitted link functions demonstrated superior model fitting compared to exposurecategorized model or linear link function model assuming proportionality of odds. Conclusion: Non-linear associations were found between air pollutants and MASLD prevalence. PM2.5, PM10, O3, CO, and NO2 exhibited positive associations with MASLD in specific concentration ranges, highlighting the need to consider non-linear relationships in assessing the impact of air pollution on MASLD.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Increased risk of cancers in metabolic dysfunction-associated steatotic liver disease and MetALD
    Park, Yewan
    Jung, Jooyi
    Kim, Gi-Ae
    JOURNAL OF HEPATOLOGY, 2024, 80 : S468 - S468
  • [42] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [43] The association between non-invasive tests of liver fibrosis and early diastolic dysfunction in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Amato, F.
    Armandi, A.
    Andreis, A.
    Bellettini, M.
    Lorusso, F.
    Gjini, K.
    Marano, M.
    Vaira, L.
    Rosso, C.
    Caviglia, G. P.
    Guariglia, M.
    Dileo, E.
    Castagno, D.
    Alunni, G.
    De Ferrari, G. M.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [44] Re-Assessing the Non-Linear Trends in the Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease From 1990 to 2021
    Lu, Fang
    She, Bingyang
    Ji, Fanpu
    Zhang, Lei
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [45] Cardiovascular Disease Risk Is Increased In Adolescents With Metabolic Dysfunction-associated Steatotic Liver Disease
    Short, Kevin R.
    Palle, Sirish K.
    Tryggestad, Jeanie B.
    Hellman, Diana A.
    Sciarrillo, Christina M.
    Emerson, Sam R.
    Friedman, Jacob E.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 680 - 680
  • [46] Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomy
    Kong, Qingyan
    Yang, Jiahui
    Kong, Diao
    Hu, Huanrui
    Li, Bei
    Peng, Wei
    Chen, Zheyu
    HEPATOBILIARY SURGERY AND NUTRITION, 2025,
  • [47] Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
    Armandi, Angelo
    Sanavia, Tiziana
    Younes, Ramy
    Caviglia, Gian Paolo
    Rosso, Chiara
    Govaere, Olivier
    Liguori, Antonio
    Francione, Paolo
    Gallego-Duran, Rocio
    Ampuero, Javier
    Pennisi, Grazia
    Aller, Rocio
    Tiniakos, Dina
    Burt, Alastair
    David, Ezio
    Vecchio, Fabio
    Maggioni, Marco
    Cabibi, Daniela
    Mcleod, Duncan
    Pareja, Maria Jesus
    Zaki, Marco Y. W.
    Stal, Per
    Kechagias, Stergios
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Grieco, Antonio
    Miele, Luca
    Fariselli, Piero
    Eslam, Mohammed
    Petta, Salvatore
    Hagstroem, Hannes
    George, Jacob
    Schattenberg, Joern M.
    Romero-Gomez, Manuel
    Anstee, Quentin Mark
    Bugianesi, Elisabetta
    GUT, 2024, 73 (05) : 825 - 834
  • [48] The Impact of Long-Term Aspirin Use on Outcomes Among Hospitalized Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Oum, Muhamad
    Iqbal, Humzah
    Haddadin, Rakahn
    Samhoun, Jalal
    Aftab, Fatimah
    Iqbal, Haroon
    Haidary, Hasib
    Alsawaf, Yahya
    Albuni, Mhd Kutaiba
    Sawaf, Bisher
    Sekhon, Sommer
    Saab, Sammy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1435 - S1435
  • [49] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [50] Association of liver fibrosis progression with non-liver-related mortality in metabolic dysfunction-associated steatotic liver disease
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Koshiyama, Yuichi
    Akita, Tomoyuki
    Kodama, Yuzo
    Tanaka, Junko
    HEPATOLOGY RESEARCH, 2025,